Nasopharyngeal carcinoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Nasopharyngeal carcinoma}} | {{Nasopharyngeal carcinoma}} | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Homa}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
| Line 15: | Line 15: | ||
* Prediction of clinical cancer outcomes evaluation of tumor metabolic activity | * Prediction of clinical cancer outcomes evaluation of tumor metabolic activity | ||
* NPC staging in combination with CT | * NPC staging in combination with CT | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:28, 8 March 2019
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma other imaging findings |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
Positron emission tomography (PET) scan may be helpful in the diagnosis of nasopharyngeal carcinoma. It is useful in the detection of residual or recurrent tumor after treatment and distant metastasis, predictional of clinical cancer outcome and PET/CT scan is used for NPC staging.
Other Imaging Studies
PET scan may be helpful in the diagnosis of nasopharyngeal carcinoma. PET scan is used for:[1][2][3][4]
- Detection of the residual or recurrent nasopharyngeal tumor after treatment
- Detection of distant metastasis
- Prediction of clinical cancer outcomes evaluation of tumor metabolic activity
- NPC staging in combination with CT
References
- ↑ Nakamoto, Yuji; Osman, Medhat; Wahl, Richard L. (2003). "Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG". Clinical Nuclear Medicine. 28 (4): 302–307. doi:10.1097/01.RLU.0000057556.54046.7A. ISSN 0363-9762.
- ↑ Yen, Ruoh-Fang; Hung, Rey-Long; Pan, Mei-Hsiu; Wang, Yao-Hung; Huang, Kou-Mou; Lui, Louis T.; Kao, Chia-Hung (2003). "18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging". Cancer. 98 (2): 283–287. doi:10.1002/cncr.11519. ISSN 0008-543X.
- ↑ Chang, K.-P.; Tsang, N.-M.; Liao, C.-T.; Hsu, C.-L.; Chung, M.-J.; Lo, C.-W.; Chan, S.-C.; Ng, S.-H.; Wang, H.-M.; Yen, T.-C. (2012). "Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma". Journal of Nuclear Medicine. 53 (1): 21–28. doi:10.2967/jnumed.111.090696. ISSN 0161-5505.
- ↑ Yang, Zhongyi; Shi, Qi; Zhang, Yongping; Pan, Herong; Yao, Zhifeng; Hu, Silong; Shi, Wei; Zhu, Beiling; Zhang, Yingjian; Hu, Chaosu (2015). "Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study". Radiation Oncology. 10 (1): 4. doi:10.1186/s13014-014-0268-5. ISSN 1748-717X.